Clinical Trial Detail

NCT ID NCT01436968
Title Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Advantagene, Inc.
Indications

prostate cancer

Therapies

Valacyclovir

AdV-tk + Valacyclovir

Age Groups: adult senior

No variant requirements are available.